nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea
|
Choi, Moon Ki |
|
2018 |
119 |
C |
p. 36-41 |
artikel |
2 |
Associations of objectively assessed physical activity and sedentary time with health-related quality of life among lung cancer survivors: A quantile regression approach
|
D’Silva, Adrijana |
|
2018 |
119 |
C |
p. 78-84 |
artikel |
3 |
Circulating tumor DNA testing in advanced non-small cell lung cancer
|
Moding, Everett J. |
|
2018 |
119 |
C |
p. 42-47 |
artikel |
4 |
Contents
|
|
|
2018 |
119 |
C |
p. v-vi |
artikel |
5 |
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma
|
Kasahara, Norimitsu |
|
2018 |
119 |
C |
p. 71-77 |
artikel |
6 |
Corrigendum to “Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation” [Lung Cancer 112, (October) (2017) 81–89]
|
Hsieh, Feng-Shu |
|
2018 |
119 |
C |
p. 127-128 |
artikel |
7 |
Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer
|
Burudpakdee, C. |
|
2018 |
119 |
C |
p. 103-111 |
artikel |
8 |
Editorial Board
|
|
|
2018 |
119 |
C |
p. iii |
artikel |
9 |
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study
|
Fujimoto, Daichi |
|
2018 |
119 |
C |
p. 14-20 |
artikel |
10 |
Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification
|
Yang, Shun-Mao |
|
2018 |
119 |
C |
p. 56-63 |
artikel |
11 |
Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients
|
Turner, Simon R. |
|
2018 |
119 |
C |
p. 85-90 |
artikel |
12 |
Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients
|
Yomo, Shoji |
|
2018 |
119 |
C |
p. 120-126 |
artikel |
13 |
Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance
|
Christopoulos, Petros |
|
2018 |
119 |
C |
p. 48-55 |
artikel |
14 |
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations
|
Sneddon, Sophie |
|
2018 |
119 |
C |
p. 64-70 |
artikel |
15 |
Nivolumab-induced severe pancytopenia in a patient with lung adenocarcinoma
|
Tokumo, Kentaro |
|
2018 |
119 |
C |
p. 21-24 |
artikel |
16 |
Physical behavior and associations with health outcomes in operable NSCLC patients: A prospective study
|
Timmerman, J.G. (Josien) |
|
2018 |
119 |
C |
p. 91-98 |
artikel |
17 |
Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors
|
Kang, Yeon-koo |
|
2018 |
119 |
C |
p. 1-6 |
artikel |
18 |
Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy
|
Borghaei, Hossein |
|
2018 |
119 |
C |
p. 112-119 |
artikel |
19 |
Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease
|
Doménech, Marta |
|
2018 |
119 |
C |
p. 99-102 |
artikel |
20 |
The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments
|
Raez, Luis E. |
|
2018 |
119 |
C |
p. 7-13 |
artikel |
21 |
Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms
|
Hegab, Ahmed E. |
|
2018 |
119 |
C |
p. 25-35 |
artikel |